Management of Acute Respiratory Distress Syndrome (ARDS) patients: A Literature Review
Abstract
In general, Acute Respiratory Distress Syndrome or ARDS is acknowledged to be the cause of 10% opatients requiring ICU care, and about 3 million patients worldwide experience it. Despite the data, up to these days there haven’t been many treatments that are considered to be effective in preventing or treating ARDS.
This research is a literature review with a narrative approach in which the researchers analyze several research articles. The present study aims to analyze the management of ARDS in reducing mortality, improving lung function and airway effectiveness. The articles were searched based on the publication year 2016-2020, with the keywords “Acute Respiratory Distress Syndrome” AND “Oxygen Saturation”, “Acute Respiratory Distress Syndrome” AND “Treatment”, “Acute Respiratory Distress Syndrome” AND “Management”; as well as the databases of PubMed, EBSCO and American Journal of Clinical Pathology.
Based on the 14 articles selected using inclusion criteria, it was found that there were 8 treatments given to the ARDS patients to reduce mortality, namely Non-Invasive Ventilation (NIV), the use of corticosteroids, UC-MSC (umbilical cord mesenchymal stem cells), oxygen therapy, mechanical ventilation, HFNC, prone position, open lung approach (OLA), and simvastatin.
Of the 8 analyzed treatments, 3 interventions were found to have the highest significance of improvement in lung function and quality improvement in several indicators such as decreased mortality rate, increased saturation, decreased hospitalization time, etc. These interventions were: (1) Non-Invasive Ventilation (p value <0.001); (2) simvastatin (p value <0.001); (3) Corticosteroid (methylprednisolone) (p value <0.001).
Full Text:
PDFReferences
Aboet, A. A., & Maskoen, T. T. (2018). Acute Respiratory Distress Syndrome ( ARDS ). Anesthesia & Critical Care, 36(2), 57–63.
Baek, M. S., Lee, Y., Hong, S. B., Lim, C. M., Koh, Y., & Huh, J. W. (2021). Effect of corticosteroid therapy in the early phase of acute respiratory distress syndrome: A propensity-matched cohort study. Korean Journal of Internal Medicine, 36(1), 145–153. https://doi.org/10.3904/kjim.2019.153
Barrot, L., Asfar, P., Mauny, F., Winiszewski, H., Montini, F., Badie, J., … Capellier, G. (2020). Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. New England Journal of Medicine, 382(11), 999–1008. https://doi.org/10.1056/nejmoa1916431
Bime, C., Fiero, M., Lu, Z., Oren, E., Berry, C. E., Parthasarathy, S., & Garcia, J. G. N. (2016). High Positive End Expiratory Pressure is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome. Physiology & Behavior, 176(1), 100–106. https://doi.org/10.1016/j.amjmed.2016.09.029.High
Calfee, C. S., Delucchi, K. L., Sinha, P., Matthay, M. A., Hackett, J., Shankar-Hari, M., … Sellors, G. (2018). Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. The Lancet Respiratory Medicine, 6(9), 691–698. https://doi.org/10.1016/S2213-2600(18)30177-2
Diamond, M., Hector L, P. F., Sanghavi, D., Sidhart, & Mahapatra. (2021). Acute Respiratory Distress Syndrome.
Fan, Brodie, & Slutsky. (2018). Acute respiratory distress syndrome advances in diagnosis and treatment. JAMA - J Am Med Associat, 319(7), 698–710.
Fatoni, A. Z., & Rakhmatullah, R. (2021). Acute Respiratory Distress Syndrome (ARDS) pada Pneumonia COVID-19. Journal of Anaesthesia and Pain, 2(1), 11–24. https://doi.org/10.21776/ub.jap.2021.002.01.02
Guérin, C., Reignier, J., Richard, J.-C., Beuret, P., Gacouin, A., Boulain, T., … Ayzac, L. (2019). Prone Positioning in Severe Acute Respiratory Distress Syndrome. New England Journal of Medicine, 368(23), 2159–2168. https://doi.org/10.1056/nejmoa1214103
Hirano, Y., Madokoro, S., Kondo, Y., Okamoto, K., & Tanaka, H. (2020). Corticosteroid treatment for early acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials. Journal of Intensive Care, 8(1), 1–8. https://doi.org/10.1186/s40560-020-00510-y
Jones, P. G., Kamona, S., Doran, O., Sawtell, F., & Wilsher, M. (2016). Randomized controlled trial of humidified high-flow nasal oxygen for acute respiratory distress in the emergency department: The HOT-ER study. Respiratory Care, 61(3), 291–299. https://doi.org/10.4187/respcare.04252
Kacmarek, R. M., Villar, J., Sulemanji, D., Montiel, R., Ferrando, C., Blanco, J., … Suárez-Sipmann, F. (2016). Open lung approach for the acute respiratory distress syndrome: A pilot, randomized controlled trial. Critical Care Medicine, 44(1), 32–42. https://doi.org/10.1097/CCM.0000000000001383
Kusuma, I. F., Trisnawati, I., & Budiono, E. (2015). Faktor-Faktor yang mempengaruhi mortalitas pasien acute respiratory distress syndrome di ICU. Indo Journal Chest Critical and Emergency Medical, 2(3), 103–106.
Lanzoni, G., Linetsky, E., Correa, D., Messinger Cayetano, S., Alvarez, R. A., Kouroupis, D., … Ricordi, C. (2021). Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Stem Cells Translational Medicine. https://doi.org/10.1002/sctm.20-0472
Lee, K., J, K., & M, P. (2011). Acute respiratory distress syndrome caused by miliary tuberculosis: a multicentre survey in South Korea. INT J TUBERC LUNG DIS, 15(8), 1099–1103.
Marco, R., R, G., & T, T. (2012). Acute respiratory distress syndrome: The Berlin definition. JAMA - Journal of the American Medical Association, 307(23), 2526–2533.
Meduri, G. U., Bridges, L., Shih, M. C., Marik, P. E., Siemieniuk, R. A. C., & Kocak, M. (2016). Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Medicine, 42(5), 829–840. https://doi.org/10.1007/s00134-015-4095-4
Patel, B. K., Wolfe, K. S., Pohlman, A. S., Hall, J. B., & Kress, J. P. (2016). Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome a randomized clinical trial. JAMA - Journal of the American Medical
DOI: https://doi.org/10.24198/pacnj.v2i2.33616
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Etika Emaliyawati, Rahdatul Aisyiyah
.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.